Your browser doesn't support javascript.
Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
Rajpal, Aman; Rahimi, Leili; Ismail-Beigi, Faramarz.
  • Rajpal A; Department of Medicine, Case Western Reserve University and Cleveland VA Medical Center, Cleveland, Ohio, USA.
  • Rahimi L; Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Ismail-Beigi F; Department of Medicine, Case Western Reserve University and Cleveland VA Medical Center, Cleveland, Ohio, USA.
J Diabetes ; 12(12): 895-908, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1096641
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus. Diabetes (mostly type 2 diabetes mellitus, T2DM) and hyperglycemia are among the major comorbidities in patients with COVID-19 leading to poor outcomes. Reports show that patients with diabetes and COVID-19 are at an increased risk for developing severe complications including acute respiratory distress syndrome, multi-organ failure, and death. Here we explore potential mechanistic links that could explain the observed higher morbidity and mortality in this patient population. Patients with T2DM have an underlying increased level of inflammation associated with obesity and insulin resistance in addition to other comorbidities including hypertension, obesity, cardiovascular disease, dyslipidemia, and being older. We review evidence that T2DM with hyperglycemia are among factors that lead to elevated expression of angiotensin-converting enzyme 2 (ACE2) in lungs and other tissues; ACE2 is the cellular "receptor" and port of viral entry. The preexisting chronic inflammation with augmented inflammatory response to the infection and the increasing viral load leads to extreme systemic immune response ("cytokine storm") that is strongly associated with increased severity of COVID-19. Based on the available evidence, it is recommended by a panel of experts that safe but stringent control of blood glucose, blood pressure, and lipids be carried out in patients with T2DM, measures that could potentially serve to decrease the severity of COVID-19 should these patients contract the viral infection. Once the infection occurs, then attention should be directed to proper glycemic control with use of insulin and frequent monitoring of blood glucose levels.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 2 / SARS-CoV-2 / COVID-19 / Inflammation / Obesity Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Diabetes Journal subject: Endocrinology Year: 2020 Document Type: Article Affiliation country: 1753-0407.13085

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 2 / SARS-CoV-2 / COVID-19 / Inflammation / Obesity Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Diabetes Journal subject: Endocrinology Year: 2020 Document Type: Article Affiliation country: 1753-0407.13085